These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7660535)

  • 21. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
    Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
    Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes control in the elderly: a randomized, comparative study of glyburide versus glipizide in non-insulin-dependent diabetes mellitus.
    Rosenstock J; Corrao PJ; Goldberg RB; Kilo C
    Clin Ther; 1993; 15(6):1031-40. PubMed ID: 8111800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suicide by combined insulin and glipizide overdose in a non-insulin dependent diabetes mellitus physician: a case report.
    Rao NG; Menezes RG; Nagesh KR; Kamath GS
    Med Sci Law; 2006 Jul; 46(3):263-9. PubMed ID: 16909651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of feline diabetes mellitus using an alpha-glucosidase inhibitor and a low-carbohydrate diet.
    Mazzaferro EM; Greco DS; Turner AS; Fettman MJ
    J Feline Med Surg; 2003 Jun; 5(3):183-9. PubMed ID: 12765629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of glipizide in the treatment of non-insulin dependent diabetes].
    Małecki M
    Przegl Lek; 1996; 53(9):663-5. PubMed ID: 8992533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of hypoglycemic drugs during lactation.
    Glatstein MM; Djokanovic N; Garcia-Bournissen F; Finkelstein Y; Koren G
    Can Fam Physician; 2009 Apr; 55(4):371-3. PubMed ID: 19366943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of hypoglycemic sulfonamides: Ozidia, a new concept].
    Selam JL
    Diabetes Metab; 1997 Nov; 23 Suppl 4():39-43. PubMed ID: 9463023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycosylated hemoglobin concentration for assessment of glycemic control in diabetic cats.
    Elliott DA; Nelson RW; Feldman EC; Neal LA
    J Vet Intern Med; 1997; 11(3):161-5. PubMed ID: 9183767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic effects of combination glipizide and human proinsulin treatment in NIDDM.
    Pasmantier R; Chaiken RL; Hirsch SR; Lebovitz HE
    Diabetes Care; 1990 Aug; 13 Suppl 3():42-6. PubMed ID: 2209343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes.
    Dezii CM; Kawabata H; Tran M
    South Med J; 2002 Jan; 95(1):68-71. PubMed ID: 11827247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
    Diabetes Care; 2010 Jun; 33(6):1224-9. PubMed ID: 20215447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study.
    Hsieh SH; Lin JD; Cheng HY; Ho C; Liou MJ
    Clin Ther; 2006 Sep; 28(9):1318-26. PubMed ID: 17062305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of glipizide treatment on response to an infused glucose load in patients with NIDDM.
    Sheu WH; Jeng CY; Fuh MM; Chen YD; Reaven GM
    Diabetes Care; 1995 Dec; 18(12):1582-7. PubMed ID: 8722055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum insulin assay: an important therapeutic tool in management of freshly diagnosed type 2 diabetes mellitus.
    Saxena T; Maheshwari S; Goyal RK
    J Assoc Physicians India; 2000 Aug; 48(8):815-7. PubMed ID: 11273476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of hyperglycemia on glipizide absorption in NIDDM patients.
    Esmatjes E; Vinuesa P; Navarro P; Rodriguez-Villar C; Gomis R; Vilardell E
    Diabetes Care; 1995 Jul; 18(7):1075-6. PubMed ID: 7555547
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathogenesis of feline diabetes mellitus.
    Lutz TA; Rand JS
    Vet Clin North Am Small Anim Pract; 1995 May; 25(3):527-52. PubMed ID: 7660530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feline diabetes mellitus: clinical use of long-acting glargine and detemir.
    Bloom CA; Rand J
    J Feline Med Surg; 2014 Mar; 16(3):205-15. PubMed ID: 24563492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of oral hypoglycemic agents in the management of patients with noninsulin-dependent diabetes mellitus.
    Lebovitz HE
    Am J Med; 1983 Nov; 75(5B):94-9. PubMed ID: 6369972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.
    Carroll MF; Izard A; Riboni K; Burge MR; Schade DS
    Diabetes Care; 2002 Dec; 25(12):2147-52. PubMed ID: 12453952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.